Cargando…

Acute interstitial nephritis with Prothionamide

Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Asnake, Molla, Henock, Andualem, Abayneh, Menigistu, Getu, Shimelis, Hailemariam, Shewangizaw, Endalkachew, Biruk, Zerihun, Dessalegn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109270/
https://www.ncbi.nlm.nih.gov/pubmed/35585853
http://dx.doi.org/10.1177/2050313X221094076
_version_ 1784708866526674944
author Asnake, Molla
Henock, Andualem
Abayneh, Menigistu
Getu, Shimelis
Hailemariam, Shewangizaw
Endalkachew, Biruk
Zerihun, Dessalegn
author_facet Asnake, Molla
Henock, Andualem
Abayneh, Menigistu
Getu, Shimelis
Hailemariam, Shewangizaw
Endalkachew, Biruk
Zerihun, Dessalegn
author_sort Asnake, Molla
collection PubMed
description Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide.
format Online
Article
Text
id pubmed-9109270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-91092702022-05-17 Acute interstitial nephritis with Prothionamide Asnake, Molla Henock, Andualem Abayneh, Menigistu Getu, Shimelis Hailemariam, Shewangizaw Endalkachew, Biruk Zerihun, Dessalegn SAGE Open Med Case Rep Case Report Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide. SAGE Publications 2022-05-13 /pmc/articles/PMC9109270/ /pubmed/35585853 http://dx.doi.org/10.1177/2050313X221094076 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Asnake, Molla
Henock, Andualem
Abayneh, Menigistu
Getu, Shimelis
Hailemariam, Shewangizaw
Endalkachew, Biruk
Zerihun, Dessalegn
Acute interstitial nephritis with Prothionamide
title Acute interstitial nephritis with Prothionamide
title_full Acute interstitial nephritis with Prothionamide
title_fullStr Acute interstitial nephritis with Prothionamide
title_full_unstemmed Acute interstitial nephritis with Prothionamide
title_short Acute interstitial nephritis with Prothionamide
title_sort acute interstitial nephritis with prothionamide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109270/
https://www.ncbi.nlm.nih.gov/pubmed/35585853
http://dx.doi.org/10.1177/2050313X221094076
work_keys_str_mv AT asnakemolla acuteinterstitialnephritiswithprothionamide
AT henockandualem acuteinterstitialnephritiswithprothionamide
AT abaynehmenigistu acuteinterstitialnephritiswithprothionamide
AT getushimelis acuteinterstitialnephritiswithprothionamide
AT hailemariamshewangizaw acuteinterstitialnephritiswithprothionamide
AT endalkachewbiruk acuteinterstitialnephritiswithprothionamide
AT zerihundessalegn acuteinterstitialnephritiswithprothionamide